Case report: Dramatic impact of DNA next generation sequencing results using specific targeted therapies—ALK and PIK3CA
Stav Cullum, Hlu Vang, Michael Glover, Howra Alammarah, Heather Morton, Nancy Pham, Mobeen Rahman, Saad A. Khan · 2024
Read Case report: Dramatic impact of DNA next generation sequencing results using specific targeted therapies—ALK and PIK3CA by Stav Cullum, Hlu Vang, Michael Glover, Howra Alammarah, Heather Morton, Nancy Pham, Mobeen Rahman, Saad A. Khan (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11628483.txt.
Description
Cullum and seven co-authors describe two cancer cases where DNA sequencing changed treatment, in this two thousand twenty-four case report. Modern sequencing can scan a tumor's genes and sometimes reveal a weakness that an existing drug can attack.
In the first patient, who had salivary gland cancer, sequencing found an ALK gene fusion, and an off-label ALK drug produced a striking response in the main tumor and its spread. In the second, an undiagnosable scalp tumor that had beaten standard care carried a PIK3CA mutation, and adding a matching drug halted its progress. The authors argue that sequencing should be used more widely to open personalized options for patients.
Catalog record
| CREATOR | Stav Cullum, Hlu Vang, Michael Glover, Howra Alammarah, Heather Morton, Nancy Pham, Mobeen Rahman, Saad A. Khan |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 15 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |